Monitor future 10-Q/K filings to see if the new segment reporting reveals any material shifts in profitability or growth trends, particularly in the CORE business excluding Infant Formula.
Price Chart
Executive Summary
Perrigo recast its historical financials to align with new product-based reporting segments introduced in Q1 2026, providing restated quarterly and annual data for 2024 and 2025. This follows the company's February 2026 earnings report that revealed a $1.3B goodwill impairment and weak guidance for FY2026. The filing is routine, aimed at improving comparability under the new structure.
Key Financial Metrics
Key Facts
- Filing recasts historical financials for 2024 and 2025 to reflect new reporting segments: Self Care, Specialty Care, Infant Formula, and All Other.
- The change is for comparability and does not restate prior financial results.
- This follows a February 2026 earnings report that included a $1.3 billion goodwill impairment and weak FY2026 guidance.
Financial Impact
No impact on consolidated financials; the recast is for segment reporting only.
Risk Factors
- The Infant Formula business remains under strategic review, creating uncertainty.
- The company's high debt level ($3.64B) and recent goodwill impairment pose financial risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001585364-26-000035 |
| Document: prgo-20260422.htm | 0001585364-26-000035 |
| Document: 0001585364-26-000035-index-headers.html | 0001585364-26-000035 |
| Document: 0001585364-26-000035-index.html | 0001585364-26-000035 |
| Document: 0001585364-26-000035.txt | 0001585364-26-000035 |
| 8-K Data (Synthetic) | 0001585364-26-000035 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 11w ago | 8-K | $13.27 | awaiting T+60 | — | $15.82 (+19.22%) |
Jun 30, 2026 16w ago | 8-K | $10.31 $14.68 | ▲ +42.39% | ▲ +39.51% | $15.82 (+53.44%) |
May 28, 2026 21w ago | 144 | $11.15 $14.25 | ▲ +27.80% | ▲ +26.07% | $15.82 (+41.88%) |
Apr 22, 2026 26w ago | 8-K | $11.68 $10.72 | ▼ −8.23% | ▼ −13.15% | $15.82 (+35.42%) |
Apr 3, 2026 29w ago | DEFA14A | $10.56 $10.31 | ▼ −2.39% | ▼ −15.56% | $15.82 (+49.78%) |
Mar 20, 2026 31w ago | DEFA14A | $9.23 $10.99 | ▲ +19.04% | ▲ +4.62% | $15.82 (+71.36%) |
Feb 26, 2026 34w ago | 8-K | $14.08 $11.35 | ▲ +19.40% | ▲ +27.15% | $15.82 (−12.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers